PathFinder
Well-known member
Hi friends,
I haven't posted for long time, since I go to the university and I am very busy, making some prjects for Mercedes.
Many of you know, that the Fibrillin-1 is the major factor in the development of the bicuspid valve disease. Its mutation or deficiency (not clear yet for me) cause the stiffnes and fragility of the great vessels (aorta and pulmonary artery).
The point is, how the fibrillin-1 expression will affect the myocardial function, as it makes the heart muscle stiffer and affects the contractility and relaxations of it. Whether there is such effect? If this effect exist, then why many BAV don't have any heart issues til their late 80's and 90's, keeping in mind, that evidenced all BAV's have the same amount of Fibrillin-1 (independently of age, valve function and aortic diameter)?
These are very interesting questions I think, and I will be very happy to see your opinions about.
Ivo
I haven't posted for long time, since I go to the university and I am very busy, making some prjects for Mercedes.
Many of you know, that the Fibrillin-1 is the major factor in the development of the bicuspid valve disease. Its mutation or deficiency (not clear yet for me) cause the stiffnes and fragility of the great vessels (aorta and pulmonary artery).
The point is, how the fibrillin-1 expression will affect the myocardial function, as it makes the heart muscle stiffer and affects the contractility and relaxations of it. Whether there is such effect? If this effect exist, then why many BAV don't have any heart issues til their late 80's and 90's, keeping in mind, that evidenced all BAV's have the same amount of Fibrillin-1 (independently of age, valve function and aortic diameter)?
These are very interesting questions I think, and I will be very happy to see your opinions about.
Ivo